RNS Number : 9086Z
PureTech Health PLC
17 January 2024
 

17 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

16 January 2024



Number of ordinary shares purchased:

96,789



Highest price paid per share:

188.00p



Lowest price paid per share:

185.40p



Volume weighted average price paid per share:

186.84p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 18,483,270 ordinary shares in treasury and has 270,984,889 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,984,889 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

16/01/2024

08:09:30

2348

187

XLON

00385394915TRLO0.1.1

16/01/2024

08:10:33

336

186.8

AQXE

00385395142TRLO0.1.1

16/01/2024

08:10:50

382

186.6

XLON

00385395193TRLO0.1.1

16/01/2024

08:10:50

205

186.6

XLON

00385395194TRLO0.1.1

16/01/2024

08:10:50

249

186.4

BATE

00385395195TRLO0.1.1

16/01/2024

08:10:50

305

186.4

CHIX

00385395197TRLO0.1.1

16/01/2024

08:10:50

156

186.4

BATE

00385395196TRLO0.1.1

16/01/2024

08:10:50

282

186.4

CHIX

00385395198TRLO0.1.1

16/01/2024

08:10:50

182

186.4

BATE

00385395199TRLO0.1.1

16/01/2024

08:10:50

198

186.4

TRQX

00385395200TRLO0.1.1

16/01/2024

08:37:46

50

186.6

XLON

00385399847TRLO0.1.1

16/01/2024

11:38:17

30

187.6

AQXE

00385425774TRLO0.1.1

16/01/2024

11:38:17

336

187.6

AQXE

00385425773TRLO0.1.1

16/01/2024

11:38:17

306

187.6

AQXE

00385425775TRLO0.1.1

16/01/2024

11:38:17

198

187.8

TRQX

00385425776TRLO0.1.1

16/01/2024

11:38:17

587

188

BATE

00385425777TRLO0.1.1

16/01/2024

11:38:17

587

187.8

CHIX

00385425779TRLO0.1.1

16/01/2024

11:38:17

587

187.8

CHIX

00385425778TRLO0.1.1

16/01/2024

11:38:17

1195

187.8

XLON

00385425792TRLO0.1.1

16/01/2024

11:38:21

418

187.2

BATE

00385425795TRLO0.1.1

16/01/2024

11:38:21

1496

186.4

XLON

00385425800TRLO0.1.1

16/01/2024

11:38:23

205

187.2

CHIX

00385425802TRLO0.1.1

16/01/2024

11:38:25

198

187.2

TRQX

00385425810TRLO0.1.1

16/01/2024

11:38:30

938

187.2

XLON

00385425819TRLO0.1.1

16/01/2024

11:38:30

584

187.2

XLON

00385425818TRLO0.1.1

16/01/2024

11:38:37

100

187.2

XLON

00385425837TRLO0.1.1

16/01/2024

12:36:32

177

187.2

XLON

00385435474TRLO0.1.1

16/01/2024

12:36:34

124

187.2

CHIX

00385435490TRLO0.1.1

16/01/2024

12:36:40

3002

187.2

XLON

00385435512TRLO0.1.1

16/01/2024

12:36:40

831

187.2

XLON

00385435514TRLO0.1.1

16/01/2024

12:48:17

42

187.2

BATE

00385437101TRLO0.1.1

16/01/2024

13:09:08

210

187.2

AQXE

00385440141TRLO0.1.1

16/01/2024

13:09:08

126

187.2

AQXE

00385440142TRLO0.1.1

16/01/2024

13:09:08

545

187.2

BATE

00385440143TRLO0.1.1

16/01/2024

13:09:08

731

187.2

CHIX

00385440144TRLO0.1.1

16/01/2024

13:09:08

587

187.2

BATE

00385440145TRLO0.1.1

16/01/2024

13:09:08

137

187.2

CHIX

00385440146TRLO0.1.1

16/01/2024

13:09:08

1290

187

XLON

00385440148TRLO0.1.1

16/01/2024

13:09:08

578

187.2

CHIX

00385440147TRLO0.1.1

16/01/2024

13:09:08

500

187

XLON

00385440149TRLO0.1.1

16/01/2024

13:09:08

500

187

XLON

00385440150TRLO0.1.1

16/01/2024

13:09:08

198

186.6

TRQX

00385440152TRLO0.1.1

16/01/2024

13:09:08

58

187

XLON

00385440151TRLO0.1.1

16/01/2024

13:09:10

525

186.8

CHIX

00385440158TRLO0.1.1

16/01/2024

13:19:58

105

186.2

CHIX

00385441868TRLO0.1.1

16/01/2024

13:43:29

529

187.2

XLON

00385445607TRLO0.1.1

16/01/2024

13:43:29

257

187.2

XLON

00385445609TRLO0.1.1

16/01/2024

13:43:29

797

187.2

XLON

00385445608TRLO0.1.1

16/01/2024

13:43:34

108

187.2

XLON

00385445627TRLO0.1.1

16/01/2024

13:43:34

252

187.2

XLON

00385445626TRLO0.1.1

16/01/2024

13:43:34

90

187.2

XLON

00385445628TRLO0.1.1

16/01/2024

13:43:39

252

187.2

XLON

00385445633TRLO0.1.1

16/01/2024

13:43:39

90

187.2

XLON

00385445635TRLO0.1.1

16/01/2024

13:43:39

108

187.2

XLON

00385445634TRLO0.1.1

16/01/2024

13:44:47

112

186.8

AQXE

00385445886TRLO0.1.1

16/01/2024

13:44:47

224

186.8

AQXE

00385445887TRLO0.1.1

16/01/2024

13:44:47

65

186.8

CHIX

00385445889TRLO0.1.1

16/01/2024

13:44:47

522

186.8

CHIX

00385445888TRLO0.1.1

16/01/2024

13:44:47

228

186.6

XLON

00385445890TRLO0.1.1

16/01/2024

13:44:47

500

186.6

XLON

00385445891TRLO0.1.1

16/01/2024

13:44:47

1033

186.6

XLON

00385445892TRLO0.1.1

16/01/2024

14:00:00

587

186.2

BATE

00385448721TRLO0.1.1

16/01/2024

14:00:00

744

186.2

CHIX

00385448722TRLO0.1.1

16/01/2024

14:00:00

587

186.2

CHIX

00385448723TRLO0.1.1

16/01/2024

14:00:00

587

186.2

BATE

00385448724TRLO0.1.1

16/01/2024

14:00:00

214

186.2

XLON

00385448725TRLO0.1.1

16/01/2024

14:00:00

336

186

AQXE

00385448727TRLO0.1.1

16/01/2024

14:00:00

1547

186.2

XLON

00385448726TRLO0.1.1

16/01/2024

14:32:01

521

186

BATE

00385455731TRLO0.1.1

16/01/2024

14:32:01

66

186

BATE

00385455732TRLO0.1.1

16/01/2024

14:32:01

587

186

BATE

00385455733TRLO0.1.1

16/01/2024

14:32:01

1128

186

XLON

00385455734TRLO0.1.1

16/01/2024

14:32:01

167

186

XLON

00385455735TRLO0.1.1

16/01/2024

14:32:01

500

186

XLON

00385455736TRLO0.1.1

16/01/2024

14:32:01

553

186

XLON

00385455737TRLO0.1.1

16/01/2024

14:39:59

126

185.6

AQXE

00385461775TRLO0.1.1

16/01/2024

14:39:59

336

185.6

AQXE

00385461774TRLO0.1.1

16/01/2024

14:39:59

431

185.6

CHIX

00385461776TRLO0.1.1

16/01/2024

14:39:59

124

185.6

CHIX

00385461777TRLO0.1.1

16/01/2024

14:39:59

28

185.6

CHIX

00385461779TRLO0.1.1

16/01/2024

14:39:59

119

185.6

CHIX

00385461780TRLO0.1.1

16/01/2024

14:39:59

2935

185.6

XLON

00385461781TRLO0.1.1

16/01/2024

14:53:52

462

185.4

CHIX

00385473516TRLO0.1.1

16/01/2024

14:53:52

74

185.4

CHIX

00385473517TRLO0.1.1

16/01/2024

14:53:53

64

185.4

CHIX

00385473519TRLO0.1.1

16/01/2024

15:29:22

418

187

BATE

00385495459TRLO0.1.1

16/01/2024

15:29:22

338

187

BATE

00385495460TRLO0.1.1

16/01/2024

15:29:24

300

187

XLON

00385495491TRLO0.1.1

16/01/2024

15:29:24

523

187

XLON

00385495492TRLO0.1.1

16/01/2024

15:35:47

1

187

XLON

00385499326TRLO0.1.1

16/01/2024

15:35:53

121

187

XLON

00385499386TRLO0.1.1

16/01/2024

15:35:53

146

187

XLON

00385499385TRLO0.1.1

16/01/2024

15:36:44

231

187

CHIX

00385499898TRLO0.1.1

16/01/2024

15:36:44

69

187

CHIX

00385499896TRLO0.1.1

16/01/2024

15:49:28

37948

187

XLON

00385506736TRLO0.1.1

16/01/2024

15:51:18

336

187

AQXE

00385507846TRLO0.1.1

16/01/2024

15:51:18

587

186.8

CHIX

00385507847TRLO0.1.1

16/01/2024

15:51:18

649

186.8

XLON

00385507848TRLO0.1.1

16/01/2024

15:51:18

500

186.8

XLON

00385507849TRLO0.1.1

16/01/2024

15:51:18

127

186.8

XLON

00385507850TRLO0.1.1

16/01/2024

15:51:18

500

186.8

XLON

00385507851TRLO0.1.1

16/01/2024

15:51:18

572

186.8

XLON

00385507852TRLO0.1.1

16/01/2024

15:56:14

308

187.2

CHIX

00385510352TRLO0.1.1

16/01/2024

15:57:32

121

186.8

CHIX

00385510827TRLO0.1.1

16/01/2024

15:57:32

411

186.8

CHIX

00385510829TRLO0.1.1

16/01/2024

15:57:32

500

186.8

BATE

00385510828TRLO0.1.1

16/01/2024

15:57:32

89

186.8

CHIX

00385510830TRLO0.1.1

16/01/2024

15:57:32

498

186.8

CHIX

00385510831TRLO0.1.1

16/01/2024

15:57:32

223

186.8

BATE

00385510833TRLO0.1.1

16/01/2024

15:57:32

87

186.8

BATE

00385510832TRLO0.1.1

16/01/2024

15:57:32

131

186.8

BATE

00385510834TRLO0.1.1

16/01/2024

15:57:32

233

186.8

BATE

00385510836TRLO0.1.1

16/01/2024

15:57:32

267

186.8

AQXE

00385510835TRLO0.1.1

16/01/2024

15:57:32

389

186.8

XLON

00385510837TRLO0.1.1

16/01/2024

15:57:32

42

186.8

XLON

00385510838TRLO0.1.1

16/01/2024

15:57:32

587

186.8

XLON

00385510840TRLO0.1.1

16/01/2024

15:57:32

743

186.8

XLON

00385510839TRLO0.1.1

16/01/2024

15:57:32

587

186.8

XLON

00385510841TRLO0.1.1

16/01/2024

15:57:32

15

186.8

AQXE

00385510843TRLO0.1.1

16/01/2024

15:57:32

88

186.8

AQXE

00385510842TRLO0.1.1

16/01/2024

16:06:02

176

186.8

XLON

00385515570TRLO0.1.1

16/01/2024

16:06:02

17

186.8

XLON

00385515571TRLO0.1.1

16/01/2024

16:07:36

249

186.8

XLON

00385516152TRLO0.1.1

16/01/2024

16:08:35

284

186.8

XLON

00385516572TRLO0.1.1

16/01/2024

16:09:14

293

186.8

XLON

00385516830TRLO0.1.1

16/01/2024

16:09:14

742

186.8

XLON

00385516831TRLO0.1.1

16/01/2024

16:13:54

89

186.8

TRQX

00385519002TRLO0.1.1

16/01/2024

16:18:38

124

186.4

AQXE

00385521628TRLO0.1.1

16/01/2024

16:18:38

56

186.4

AQXE

00385521629TRLO0.1.1

16/01/2024

16:19:55

381

186.8

XLON

00385522159TRLO0.1.1

16/01/2024

16:20:34

390

186.8

XLON

00385522613TRLO0.1.1

16/01/2024

16:21:07

411

186.8

XLON

00385522914TRLO0.1.1

16/01/2024

16:21:33

530

186.8

XLON

00385523092TRLO0.1.1

16/01/2024

16:21:33

378

186.8

XLON

00385523091TRLO0.1.1

16/01/2024

16:21:33

587

186.4

BATE

00385523093TRLO0.1.1

16/01/2024

16:21:33

313

186.4

CHIX

00385523094TRLO0.1.1

16/01/2024

16:21:33

200

186.4

CHIX

00385523095TRLO0.1.1

16/01/2024

16:22:10

1

186.6

TRQX

00385523360TRLO0.1.1

16/01/2024

16:22:26

995

186.6

XLON

00385523512TRLO0.1.1

16/01/2024

16:29:22

500

186.6

BATE

00385526630TRLO0.1.1

16/01/2024

16:29:22

87

186.6

BATE

00385526631TRLO0.1.1

16/01/2024

16:29:22

500

186.6

XLON

00385526632TRLO0.1.1

16/01/2024

16:29:22

87

186.6

XLON

00385526633TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLTLVIRLIS